Logo image
Se connecter
Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy
Article de revue   Avec comité de lecture

Regional disparities in cost-effectiveness of biologics for CRSwNP should not modify the strategy

M Fieux, F Carsuzaa, M Chang, P H Hwang, Z M Patel, S Tringali, V Favier et J Margier
Rhinology
05/01/2026
PMID: 41486827

Résumé

Chronic rhinosinusitis with nasal polyps (CRSwNP) represents a significant burden on the healthcare system. Xian et al. discussed several aspects of our economic model, based on French pricing, that may impact the cost-effectiveness of biologics . Briefly, they outlined the regional disparities in the cost of biologics, the potential better outcomes of biologics in real-world evidence, and the recurrence rate after endoscopic sinus surgery (ESS). We think that these aspects may be further discussed.

Indicateurs

1 Consultations de la notice

Détails

Logo image